NeVa / NeVa VS
Acute Ischemic Stroke (Large Vessel Occlusion)
CommercialActive
Key Facts
About Vesalio
Vesalio is a private, commercial-stage medical device company developing novel thrombectomy technologies for acute vascular occlusions across multiple territories, including stroke, heart attack, and peripheral arterial disease. Its core innovation is the patented Drop Zone technology, designed to improve first-pass success and clot retention. The company has achieved significant regulatory milestones, including FDA clearance and CE Mark for its flagship products, positioning it in large, high-need cardiovascular markets.
View full company profileOther Acute Ischemic Stroke (Large Vessel Occlusion) Drugs
| Drug | Company | Phase |
|---|---|---|
| FreeClimb Catheter Systems (54, 70, 88) | Route 92 Medical | Approved |
| HiPoint Reperfusion System | Route 92 Medical | Pivotal Trial |
| Lead Ischemic Stroke Program | RapidPulse | Pivotal |
| Millipede 088 Aspiration Catheter | Perfuze | Pivotal Trial (IDE) |